Skip to main content

Iridex Corp

IRIX
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001006045

In the last 90 days, Iridex Corp insiders filed 4 open-market purchases and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.47M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Iridex Corp changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of IRIX: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders3132+1
Shares3.55M3.26M−289.7K (−8.2%)
Value$9.03M$9.17M+$141.0K (+1.6%)

New holders (5)

Institutions that held Iridex Corp at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to IRIX in Q4 2023
InstitutionSharesValue% of portfolio
XTX Topco Ltd14,729$41.4K0.01%
UBS Group AG6,791$19.1K0.00%
Simplex Trading, LLC3,566$10.0K0.00%
Group One Trading, L.P.440$1.24K0.00%
Bank of America Corp8$220.00%

Sold out (4)

Institutions that held Iridex Corp at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of IRIX in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Neuberger Berman Group LLC75,850$192.7K
Acadian Asset Management LLC28,807$73.0K
Mackenzie Financial Corp21,438$58.7K
Citigroup Inc5,668$14.4K